| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Revenue | $2.87B (+19% YoY) | $2.77B (+23% YoY) | +400 bps acceleration despite $100M sequential decline |
| Procedure Growth | 18% total procedures | 17% total procedures | 100 bps deceleration |
| dV Procedure Growth | 17% | 16% | 100 bps deceleration |
| Operating Margin | 37% | 39% | +200 bps expansion |
| Gross Margin | 67.8% | 67.8% | Flat despite mix headwinds |
| System Placements | 532 dV systems | 431 dV systems | 100 system decline, -19% |
| I&A Revenue Growth | 17% | 23% | +600 bps acceleration |
| I&A RPP | ~$1,850 | ~$1,880 | +$30 per procedure |
| U.S. Utilization Growth | 3% | 4% | +100 bps acceleration |
| Cash Position | $9.0B | $8.0B | $1B decline from buybacks |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.